↓ Skip to main content

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, November 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
16 Mendeley